The growing government initiative, program, campaign, and product launches by prominent key players for the prevention and control of diabetes further propel the market growth during the projected period
Pipeline outlook for oral GLP-1 drugs
Science has shown that obesity is not a problem that must be overcome solely by your own willpower the gut may play a large role in preventing the weight loss you are looking for
The action of 8-Br-cAMP was reversible
Reference: Weight regain after cessation of medication for weight management: systematic review and meta-analysis by Sam West, Jadine Scragg, Paul Aveyard, Jason L Oke, Lia Willis, Stella J P Haffner, Heather Knight, Danni Wang, Sarah Morrow, Laura Heath, Susan A Jebb and Dimitrios A Koutoukidis, 7 January 2026, BMJ
A Final Note & Gentle PSA on the GLP-1 Pipeline On the topic of GLP-1 misinformation, I'd like to share something from a webinar that really irked me, particularly in terms of the direction this GLP-1 marketing blitz is headed